Aix Marseille University, INSERM, INRA, C2VN, Marseille, France
Search for other papers by Sandrine Visentin in
Google Scholar
PubMed
Research Unit EA 3279 and Department of Public Health, Aix-Marseille University, Marseille, France
Search for other papers by Gérard Michel in
Google Scholar
PubMed
Research Unit EA 3279 and Department of Public Health, Aix-Marseille University, Marseille, France
Search for other papers by Claire Oudin in
Google Scholar
PubMed
Search for other papers by Béatrice Cousin in
Google Scholar
PubMed
Search for other papers by Bénédicte Gaborit in
Google Scholar
PubMed
Search for other papers by Inès Abdesselam in
Google Scholar
PubMed
Search for other papers by Marie Maraninchi in
Google Scholar
PubMed
Search for other papers by Marion Nowicki in
Google Scholar
PubMed
Nutrition, Metabolic Diseases and Endocrinology Department, AP-HM, La Conception Hospital, Marseille, France
Search for other papers by René Valéro in
Google Scholar
PubMed
Search for other papers by Maxime Guye in
Google Scholar
PubMed
Aix-Marseille University, CNRS, CRMBM, Marseille, France
Search for other papers by Monique Bernard in
Google Scholar
PubMed
Search for other papers by Pascal Auquier in
Google Scholar
PubMed
Search for other papers by Hervé Chambost in
Google Scholar
PubMed
Search for other papers by Marie-Christine Alessi in
Google Scholar
PubMed
Nutrition, Metabolic Diseases and Endocrinology Department, AP-HM, La Conception Hospital, Marseille, France
Search for other papers by Sophie Béliard in
Google Scholar
PubMed
(Quantikine Human Adiponectin, R&D Systems) and leptin (Active Human Leptin DSL Systems). The insulin resistance homeostasis model (HOMA-IR) was calculated as: fasting plasma glucose (mmol/L) × fasting plasma insulin (mIU/L)/22.5. Body composition and AT
Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia
Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
Search for other papers by Stefano Mangiola in
Google Scholar
PubMed
Search for other papers by Ryan Stuchbery in
Google Scholar
PubMed
Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
Search for other papers by Patrick McCoy in
Google Scholar
PubMed
Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
Search for other papers by Ken Chow in
Google Scholar
PubMed
Australian Prostate Cancer Research Centre Epworth, Richmond, Victoria, Australia
Ontario Institute for Cancer Research, Toronto, Canada
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Search for other papers by Natalie Kurganovs in
Google Scholar
PubMed
Search for other papers by Michael Kerger in
Google Scholar
PubMed
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Anthony Papenfuss in
Google Scholar
PubMed
Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
Search for other papers by Christopher M Hovens in
Google Scholar
PubMed
Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia
Department of Urology, Frankston Hospital, Frankston, Victoria, Australia
Search for other papers by Niall M Corcoran in
Google Scholar
PubMed
.1080/10408398.2011.651177 ) 24915409 10.1080/10408398.2011.651177 7 van Londen GJ Levy ME Perera S Nelson JB Greenspan SL . Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study . Critical Reviews in Oncology/Hematology 2008
Search for other papers by Kennett Sprogøe in
Google Scholar
PubMed
Search for other papers by Eva Mortensen in
Google Scholar
PubMed
Search for other papers by David B Karpf in
Google Scholar
PubMed
Search for other papers by Jonathan A Leff in
Google Scholar
PubMed
tolerability. These include increased bone growth and mineral deposition, muscle mass gain with improved exercise tolerance and enhanced lipolysis with body composition optimization, and yet, without increased immunogenicity, metabolic complications, injection
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alexandra Kulle in
Google Scholar
PubMed
Search for other papers by Juliane Rothermel in
Google Scholar
PubMed
Search for other papers by Caroline Knop-Schmenn in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Christina Bosse in
Google Scholar
PubMed
Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed
of our knowledge, this is the first study analyzing the longitudinal relationships between a comprehensive steroid profile encompassing androgens and their precursors, estrogens, glucocorticoids, mineralocorticoids as well as body composition
Search for other papers by Devis Pascut in
Google Scholar
PubMed
Search for other papers by Sofia Tamini in
Google Scholar
PubMed
Search for other papers by Silvia Bresolin in
Google Scholar
PubMed
Search for other papers by Pablo Giraudi in
Google Scholar
PubMed
Search for other papers by Giuseppe Basso in
Google Scholar
PubMed
Division of Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Alessandro Minocci in
Google Scholar
PubMed
Search for other papers by Claudio Tiribelli in
Google Scholar
PubMed
Division of Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Graziano Grugni in
Google Scholar
PubMed
Division of Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Division of Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Alessandro Sartorio in
Google Scholar
PubMed
subjects with common obesity ( 8 ). Accordingly to this peculiar body composition, individuals with PWS are characterised by lower insulin levels and higher insulin sensitivity as opposed to obese controls ( 9 ). Regardless of their metabolic advantages
Search for other papers by Tatsuya Kondo in
Google Scholar
PubMed
Search for other papers by Nobukazu Miyakawa in
Google Scholar
PubMed
Search for other papers by Sayaka Kitano in
Google Scholar
PubMed
Search for other papers by Takuro Watanabe in
Google Scholar
PubMed
Search for other papers by Rieko Goto in
Google Scholar
PubMed
Search for other papers by Mary Ann Suico in
Google Scholar
PubMed
Search for other papers by Miki Sato in
Google Scholar
PubMed
Search for other papers by Yuki Takaki in
Google Scholar
PubMed
Search for other papers by Masaji Sakaguchi in
Google Scholar
PubMed
Search for other papers by Motoyuki Igata in
Google Scholar
PubMed
Search for other papers by Junji Kawashima in
Google Scholar
PubMed
Search for other papers by Hiroyuki Motoshima in
Google Scholar
PubMed
Search for other papers by Takeshi Matsumura in
Google Scholar
PubMed
Search for other papers by Hirofumi Kai in
Google Scholar
PubMed
Search for other papers by Eiichi Araki in
Google Scholar
PubMed
could be expected in metabolic syndrome or type 2 diabetes compared with those in healthy subjects. Changes in body compositions and biochemical markers on HS + MES treatment were summarized in Table 2 . Table 2 Changes in body composition and
Non-Communicable Diseases Research Unit, South African Medical Council, Tygerberg, South Africa
Search for other papers by Melony C Fortuin-de Smidt in
Google Scholar
PubMed
Non-Communicable Diseases Research Unit, South African Medical Council, Tygerberg, South Africa
Search for other papers by Amy E Mendham in
Google Scholar
PubMed
Search for other papers by Jon Hauksson in
Google Scholar
PubMed
The Modern Pioneer Center and ArSMRM for MRI Training and Development, Tripoli, Libya
Search for other papers by Ali Alhamud in
Google Scholar
PubMed
Search for other papers by Darko Stefanovski in
Google Scholar
PubMed
Search for other papers by Olah Hakim in
Google Scholar
PubMed
Search for other papers by Jeroen Swart in
Google Scholar
PubMed
Search for other papers by Louise M Goff in
Google Scholar
PubMed
Search for other papers by Steven E Kahn in
Google Scholar
PubMed
Search for other papers by Tommy Olsson in
Google Scholar
PubMed
Non-Communicable Diseases Research Unit, South African Medical Council, Tygerberg, South Africa
Search for other papers by Julia H Goedecke in
Google Scholar
PubMed
), hypertension (BP ≥ 140/90 mmHg), diabetes (HbA1c > 6.5%), anaemia (haemoglobin <12 g/dL)), pregnant, lactating or smoking. After written informed consent was obtained, patients were screened for inclusion. Body composition Anthropometry included weight
Search for other papers by Sakina Kherra in
Google Scholar
PubMed
Search for other papers by Wendy Forsyth Paterson in
Google Scholar
PubMed
Search for other papers by Filiz Mine Cizmecioglu in
Google Scholar
PubMed
Search for other papers by Jeremy Huw Jones in
Google Scholar
PubMed
Search for other papers by Mariam Kourime in
Google Scholar
PubMed
Search for other papers by Heba Hassan Elsedfy in
Google Scholar
PubMed
Search for other papers by Sameh Tawfik in
Google Scholar
PubMed
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Search for other papers by Mohamad Guftar Shaikh in
Google Scholar
PubMed
Search for other papers by Malcolm David Cairns Donaldson in
Google Scholar
PubMed
sex steroid replacement therapy on metabolic health and body composition in PWS ( 33 ). Kido et al . in an adult study of 22 PWS males given 125 mg of intramuscular testosterone monthly for 2 years showed improvement in body fat, lean muscle mass and
Department of Science and Environment, Roskilde University, Roskilde, Denmark
Search for other papers by Pernille Bækgaard Udesen in
Google Scholar
PubMed
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Search for other papers by Anja Elaine Sørensen in
Google Scholar
PubMed
Search for other papers by Rikke Svendsen in
Google Scholar
PubMed
Department of Clinical Immunology, Næstved Hospital, Næstved, Denmark
Search for other papers by Nanna Louise Skov Nielsen in
Google Scholar
PubMed
Search for other papers by Marie Louise Muff Wissing in
Google Scholar
PubMed
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Search for other papers by Anne Lis Mikkelsen Englund in
Google Scholar
PubMed
Search for other papers by Louise Torp Dalgaard in
Google Scholar
PubMed
increased SHBG levels and decreased free testosterone. Combined treatment with metformin and OCP improved body composition and FG-score compared with OCP, and SHBG-levels increased by OCP or metformin + OCP treatment compared with metformin alone ( 30 ). The
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
and early postnatal periods in boys . Acta Endocrinologica 1984 105 271 – 274 . ( https://doi.org/10.1530/acta.0.1050271 ) 27 Davis SM Kaar JL Ringham BM Hockett CW Glueck DH & Dabelea D . Sex differences in infant body composition emerge in the